Help ?

IGMIN: あなたがここにいてくれて嬉しいです. お願いクリック '新しいクエリを作成してください' 当ウェブサイトへの初めてのご訪問で、さらに情報が必要な場合は.

すでに私たちのネットワークのメンバーで、すでに提出した質問に関する進展を追跡する必要がある場合は, クリック '私のクエリに連れて行ってください.'

Subjects Content

Welcome to IgMin Research – an Open Access journal uniting Biology Group, Medicine Group, and Engineering Group. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.

Biology Group

The Biology Group explores diverse topics in life sciences, providing open access to cutting-edge research and fostering global collaboration in biological studies.

Medicine Group

The Medicine Group focuses on advancing medical knowledge through open access research, promoting innovation, and encouraging global collaboration in healthcare studies.

Engineering Group

The Engineering Group showcases cutting-edge research across engineering fields, providing open access and encouraging global collaboration and innovation.

General Science Group

The General Science Group covers a broad range of scientific disciplines, offering open access to research that drives innovation and fosters global collaboration.

Members Content

Our vision is to be a bridge for scientific fields, fostering dialogue and rapid progress.

Articles Content

Our vision is to be a bridge for scientific fields, fostering dialogue and rapid progress.

Identify Us

Our vision is to be a bridge for scientific fields, fostering dialogue and rapid progress.

IgMin Corporation

Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.

Publications Support
publications.support@igmin.org
E-Books Support
ebooks.support@igmin.org
Webinars & Conferences Support
webinarsandconference@igmin.org
Content Writing Support
contentwriting.support@igmin.org

Search

Explore Section

Content for the explore section slider goes here.

Abstract

要約 at IgMin Research

Our vision is to be a bridge for scientific fields, fostering dialogue and rapid progress.

Medicine Group Mini Review 記事ID: igmin241

A Case of Facial Erysipelas with Necrosis of the Upper Eyelid

Dentistry Affiliation

Affiliation

要約

Erysipelas is a superficial cutaneous process that is usually restricted to the dermis, but with prominent lymphatic involvement commonly caused by streptococci. Here, we report an unusual case of primary gangrenous-phlegmonous erysipelas of the face with necrosis of the upper eyelid. Diagnosing facial erysipelas in this case was particularly challenging due to the atypical clinical and laboratory features, possibly caused by secondary immunodeficiency. A unique aspect of this case is that the disease started without the typical early symptoms, such as a prodrome. The patient did not initially show signs of general intoxication but instead presented with a local skin lesion before developing a fever. The characteristic redness and distinct borders commonly associated with erysipelas were also absent. This case demonstrates primary erysipelas of the face in a gangrenous-phlegmonous form, resulting in the development of upper eyelid necrosis.
Key clinical message: Recognizing atypical cases, such as the one presented, is of utmost importance. It is crucial for quick and adequate surgical and therapeutic intervention. This knowledge equips medical professionals with the necessary skills to handle similar situations in the future. The presented clinical case testifies the effectiveness of using A-PRF-membrane to prevent scar formation during wound healing.

数字

参考文献

    1. Hallab L, Taleb B. Facial Erysipelas: A Case Report. Integrative Journal of Medical Sciences. 2021;8. https://doi.org/10.15342/ijms.2021.315
    2. Ezemma O, Korman AM, Wang HE, Kaffenberger B. Diagnostic methods for the confirmation of non-purulent cellulitis: a review. Arch Dermatol Res. 2023 Nov;315(9):2519-2527. doi: 10.1007/s00403-023-02658-7. Epub 2023 Jul 8. PMID: 37421422.
    3. Brishkoska-Boshkovski V, Dimitrovska I, Kondova-Topuzovska I. Clinical Presentation and Laboratory Characteristics in Acute and Recurrent Erysipelas. Open Access Maced J Med Sci. 2019 Mar 14;7(5):771-774. doi: 10.3889/oamjms.2019.213. PMID: 30962836; PMCID: PMC6447339.
    4. Kozłowska D, Myśliwiec H, Kiluk P, Baran A, Milewska AJ, Flisiak I. Clinical and epidemiological assessment of patients hospitalized for primary and recurrent erysipelas. Przegl Epidemiol. 2016;70(4):575-584. English, Polish. PMID: 28221013.
    5. Andreychyn MA(Ed.). Infectious diseases in general practice and family medicine. TDMU "Ukrmedknyha" 2007 [in Ukrainian].
    6. Sadighi Akha AA, Csomós K, Ujházi B, Walter JE, Kumánovics A. Evolving Approach to Clinical Cytometry for Immunodeficiencies and Other Immune Disorders. Clin Lab Med. 2023 Sep;43(3):467-483. doi: 10.1016/j.cll.2023.05.002. Epub 2023 Jun 9. PMID: 37481324.
    7. Shapoval SD, Vasylevska LA, Bielinska VO. Clinical features and principles of differential diagnosis of erysipelas. The Ukrainian Journal of Clinical Surgery. 2021 Mar 28; 88(1-2):61-8. doi: 10.26779/2522-1396.2021.1-2.61
    8. Michael Y, Shaukat NM. Erysipelas. 2023 Aug 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30335280.
    9. Plagens-Rotman K, Przybylska R, Gerke K, Adamski Z, Czarnecka-Operacz M. 55-year old woman with erysipelas. Postepy Dermatol Alergol. 2020 Aug;37(4):613-616. doi: 10.5114/ada.2020.98225. Epub 2020 Sep 2. PMID: 32994788; PMCID: PMC7507150.
    10. Krasagakis K, Valachis A, Maniatakis P, Krüger-Krasagakis S, Samonis G, Tosca AD. Analysis of epidemiology, clinical features and management of erysipelas. Int J Dermatol. 2010 Sep;49(9):1012-7. doi: 10.1111/j.1365-4632.2010.04464.x. PMID: 20931671.
    11. Scarano A, Inchingolo F, Scogna G, Leo L, Crisante A, Greco Lucchina A, Lorusso F. Xanthelasma palpebrarum removed with Atmospheric Plasma technique: 11-year follow up. J Biol Regul Homeost Agents. 2021 Mar-Apr;35(2 Suppl. 1):181-185. doi: 10.23812/21-2supp1-18. PMID: 34281315.
    12. Datta I, Casanas B, Vincent AL, Greene JN. The red face: Erysipelas versus, parvovirus B19, SLE, and rosacea. Asian Biomed. 2009 Dec 1; 3:681-8.
    13. Buckland GT 3rd, Carlson JA, Meyer DR. Persistent periorbital and facial lymphedema associated with Group A beta-hemolytic streptococcal infection (erysipelas). Ophthalmic Plast Reconstr Surg. 2007 Mar-Apr;23(2):161-3. doi: 10.1097/01.iop.0000256161.79015.38. PMID: 17413641.
    14. Nadeem A, Espinosa JA, Lucerna AA. Case Report: Erysipelas Diagnosed in the Emergency Department.
    15. Brindle R, Williams OM, Barton E, Featherstone P. Assessment of Antibiotic Treatment of Cellulitis and Erysipelas: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019 Sep 1;155(9):1033-1040. doi: 10.1001/jamadermatol.2019.0884. PMID: 31188407; PMCID: PMC6563587.
    16. Klotz C, Courjon J, Michelangeli C, Demonchy E, Ruimy R, Roger PM. Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome. Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):703-709. doi: 10.1007/s10096-019-03490-6. Epub 2019 Jan 26. PMID: 30685804.
    17. Miron RJ, Pinto NR, Quirynen M, Ghanaati S. Standardization of relative centrifugal forces in studies related to platelet-rich fibrin. J Periodontol. 2019 Aug;90(8):817-820. doi: 10.1002/JPER.18-0553. Epub 2019 Mar 1. PMID: 30730050.
    18. Clark D, Rajendran Y, Paydar S, Ho S, Cox D, Ryder M, Dollard J, Kao RT. Advanced platelet-rich fibrin and freeze-dried bone allograft for ridge preservation: A randomized controlled clinical trial. J Periodontol. 2018 Apr;89(4):379-387. doi: 10.1002/JPER.17-0466. PMID: 29683498; PMCID: PMC6483085.
    19. Caruana A, Savina D, Macedo JP, Soares SC. From Platelet-Rich Plasma to Advanced Platelet-Rich Fibrin: Biological Achievements and Clinical Advances in Modern Surgery. Eur J Dent. 2019 May;13(2):280-286. doi: 10.1055/s-0039-1696585. Epub 2019 Sep 11. PMID: 31509878; PMCID: PMC6777161.
    20. Titou H, Ebongo C, Bouati E, Boui M. Risk factors associated with local complications of erysipelas: a retrospective study of 152 cases. Pan Afr Med J. 2017 Feb 5;26:66. doi: 10.11604/pamj.2017.26.66.11096. PMID: 28451043; PMCID: PMC5398858.

類似の記事

Auxological Status of Modern Primary School Students of Nizhny Novgorod Region
Kalyuzhny Evgeniy Aleksandrovich, Mukhina Irina Vasilievna, Bogomolova Elena Sergeevna, Galova Elena Anatolyevna, Puzhak Svetlana Andreevna and Baklanova Ekaterina Sergeevna
DOI10.61927/igmin219
Integrated Multi-fidelity Structural Optimization for UAV Wings
Sanusi Muhammad Babansoro, Deng Zhongmin, Hasan Mehedi and SM Tarikul Islam
DOI10.61927/igmin191

ソーシャルアイコン

研究を公開する

私たちは、科学、技術、工学、医学に関する幅広い種類の記事を編集上の偏見なく公開しています。

提出する

見る 原稿のガイドライン 追加 論文処理料

IgMin 科目を探索する
グーグルスカラー
welcome Image

Google Scholarは2004年11月にベータ版が発表され、幅広い学術領域を航海する学術ナビゲーターとして機能します。それは査読付きジャーナル、書籍、会議論文、論文、博士論文、プレプリント、要約、技術報告書、裁判所の意見、特許をカバーしています。 IgMin の記事を検索